aluates Reports

$ 0.0

Automative

Global Epigenetics Diagnostic Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-27C5748

Global Epigenetics Diagnostic Market Insights and Forecast to 2028

BUY CHAPTERS

Global Epigenetics Diagnostic Market Insights, Forecast to 2030

Code: QYRE-Auto-27C5748

Report

December 2024

Pages:106

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche Diagnostics

Thermo Fisher Scientific Inc

Eisai Co Ltd

Novartis

Illumina Inc

Merck

Qiagen NV

Abcam

Diagenode Diagnostics

Active Motif

Zymo Research Corporation

CellCentric

ValiRx Plc

Epigenetics Diagnostic Market Size

The global Epigenetics Diagnostic market is projected to grow from US$ 6180.7 million in 2024 to US$ 14450 million by 2030, at a Compound Annual Growth Rate (CAGR) of 15.2% during the forecast period.

Epigenetics Diagnostic Market

The relative specificity of many epigenetic changes for neoplastic cells has allowed the identification of diagnostic, prognostic and predictive biomarkers for a number of solid tumors and hematological malignancies.

Market Analysis and Insights: Global Epigenetics Diagnostic Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Epigenetics Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Epigenetics Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Epigenetics Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Epigenetics Diagnostic revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Epigenetics Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Epigenetics Diagnostic revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Epigenetics Diagnostic Market Report

Report Metric	Details
Report Name	Epigenetics Diagnostic Market
Accounted market size in 2024	US$ 6180.7 million
Forecasted market size in 2030	US$ 14450 million
CAGR	15.2
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Reagents Kits Instruments Enzymes Services
Segment by Application	Oncolog Non-oncology
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Diagnostics, Thermo Fisher Scientific, Inc., Eisai Co. Ltd., Novartis AG, Illumina, Inc., Merck, Qiagen, Abcam plc, Diagenode Diagnostics, Active Motif, Zymo Research Corporation, CellCentric, Valirx
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Epigenetics Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epigenetics Diagnostic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epigenetics Diagnostic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Epigenetics Diagnostic Market growing?

Ans: The Epigenetics Diagnostic Market witnessing a CAGR of 15.2 during the forecast period 2025-2030.

What is the Epigenetics Diagnostic Market size in 2030?

Ans: The Epigenetics Diagnostic Market size in 2030 will be US$ 14450 million.

Who are the main players in the Epigenetics Diagnostic Market report?

Ans: The main players in the Epigenetics Diagnostic Market are Roche Diagnostics, Thermo Fisher Scientific, Inc., Eisai Co. Ltd., Novartis AG, Illumina, Inc., Merck, Qiagen, Abcam plc, Diagenode Diagnostics, Active Motif, Zymo Research Corporation, CellCentric, Valirx

What are the Application segmentation covered in the Epigenetics Diagnostic Market report?

Ans: The Applications covered in the Epigenetics Diagnostic Market report are Oncolog, Non-oncology

What are the Type segmentation covered in the Epigenetics Diagnostic Market report?

Ans: The Types covered in the Epigenetics Diagnostic Market report are Reagents, Kits, Instruments, Enzymes, Services

Recommended Reports

Cancer Diagnostics

Molecular Diagnostics

Emerging Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Epigenetics Diagnostic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Reagents

1.2.3 Kits

1.2.4 Instruments

1.2.5 Enzymes

1.2.6 Services

1.3 Market by Application

1.3.1 Global Epigenetics Diagnostic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Oncolog

1.3.3 Non-oncology

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Epigenetics Diagnostic Market Perspective (2019-2030)

2.2 Global Epigenetics Diagnostic Growth Trends by Region

2.2.1 Epigenetics Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Epigenetics Diagnostic Historic Market Size by Region (2019-2024)

2.2.3 Epigenetics Diagnostic Forecasted Market Size by Region (2025-2030)

2.3 Epigenetics Diagnostic Market Dynamics

2.3.1 Epigenetics Diagnostic Industry Trends

2.3.2 Epigenetics Diagnostic Market Drivers

2.3.3 Epigenetics Diagnostic Market Challenges

2.3.4 Epigenetics Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Epigenetics Diagnostic by Players

3.1.1 Global Epigenetics Diagnostic Revenue by Players (2019-2024)

3.1.2 Global Epigenetics Diagnostic Revenue Market Share by Players (2019-2024)

3.2 Global Epigenetics Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Epigenetics Diagnostic, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Epigenetics Diagnostic Market Concentration Ratio

3.4.1 Global Epigenetics Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Epigenetics Diagnostic Revenue in 2023

3.5 Global Key Players of Epigenetics Diagnostic Head office and Area Served

3.6 Global Key Players of Epigenetics Diagnostic, Product and Application

3.7 Global Key Players of Epigenetics Diagnostic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Epigenetics Diagnostic Breakdown Data by Type

4.1 Global Epigenetics Diagnostic Historic Market Size by Type (2019-2024)

4.2 Global Epigenetics Diagnostic Forecasted Market Size by Type (2025-2030)

5 Epigenetics Diagnostic Breakdown Data by Application

5.1 Global Epigenetics Diagnostic Historic Market Size by Application (2019-2024)

5.2 Global Epigenetics Diagnostic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Epigenetics Diagnostic Market Size (2019-2030)

6.2 North America Epigenetics Diagnostic Market Size by Type

6.2.1 North America Epigenetics Diagnostic Market Size by Type (2019-2024)

6.2.2 North America Epigenetics Diagnostic Market Size by Type (2025-2030)

6.2.3 North America Epigenetics Diagnostic Market Share by Type (2019-2030)

6.3 North America Epigenetics Diagnostic Market Size by Application

6.3.1 North America Epigenetics Diagnostic Market Size by Application (2019-2024)

6.3.2 North America Epigenetics Diagnostic Market Size by Application (2025-2030)

6.3.3 North America Epigenetics Diagnostic Market Share by Application (2019-2030)

6.4 North America Epigenetics Diagnostic Market Size by Country

6.4.1 North America Epigenetics Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Epigenetics Diagnostic Market Size by Country (2019-2024)

6.4.3 North America Epigenetics Diagnostic Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Epigenetics Diagnostic Market Size (2019-2030)

7.2 Europe Epigenetics Diagnostic Market Size by Type

7.2.1 Europe Epigenetics Diagnostic Market Size by Type (2019-2024)

7.2.2 Europe Epigenetics Diagnostic Market Size by Type (2025-2030)

7.2.3 Europe Epigenetics Diagnostic Market Share by Type (2019-2030)

7.3 Europe Epigenetics Diagnostic Market Size by Application

7.3.1 Europe Epigenetics Diagnostic Market Size by Application (2019-2024)

7.3.2 Europe Epigenetics Diagnostic Market Size by Application (2025-2030)

7.3.3 Europe Epigenetics Diagnostic Market Share by Application (2019-2030)

7.4 Europe Epigenetics Diagnostic Market Size by Country

7.4.1 Europe Epigenetics Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Epigenetics Diagnostic Market Size by Country (2019-2024)

7.4.3 Europe Epigenetics Diagnostic Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Epigenetics Diagnostic Market Size (2019-2030)

8.2 China Epigenetics Diagnostic Market Size by Type

8.2.1 China Epigenetics Diagnostic Market Size by Type (2019-2024)

8.2.2 China Epigenetics Diagnostic Market Size by Type (2025-2030)

8.2.3 China Epigenetics Diagnostic Market Share by Type (2019-2030)

8.3 China Epigenetics Diagnostic Market Size by Application

8.3.1 China Epigenetics Diagnostic Market Size by Application (2019-2024)

8.3.2 China Epigenetics Diagnostic Market Size by Application (2025-2030)

8.3.3 China Epigenetics Diagnostic Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Epigenetics Diagnostic Market Size (2019-2030)

9.2 Asia Epigenetics Diagnostic Market Size by Type

9.2.1 Asia Epigenetics Diagnostic Market Size by Type (2019-2024)

9.2.2 Asia Epigenetics Diagnostic Market Size by Type (2025-2030)

9.2.3 Asia Epigenetics Diagnostic Market Share by Type (2019-2030)

9.3 Asia Epigenetics Diagnostic Market Size by Application

9.3.1 Asia Epigenetics Diagnostic Market Size by Application (2019-2024)

9.3.2 Asia Epigenetics Diagnostic Market Size by Application (2025-2030)

9.3.3 Asia Epigenetics Diagnostic Market Share by Application (2019-2030)

9.4 Asia Epigenetics Diagnostic Market Size by Region

9.4.1 Asia Epigenetics Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Epigenetics Diagnostic Market Size by Region (2019-2024)

9.4.3 Asia Epigenetics Diagnostic Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Type

10.2.1 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Application

10.3.1 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Country

10.4.1 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche Diagnostics

11.1.1 Roche Diagnostics Company Details

11.1.2 Roche Diagnostics Business Overview

11.1.3 Roche Diagnostics Epigenetics Diagnostic Introduction

11.1.4 Roche Diagnostics Revenue in Epigenetics Diagnostic Business (2019-2024)

11.1.5 Roche Diagnostics Recent Developments

11.2 Thermo Fisher Scientific, Inc.

11.2.1 Thermo Fisher Scientific, Inc. Company Details

11.2.2 Thermo Fisher Scientific, Inc. Business Overview

11.2.3 Thermo Fisher Scientific, Inc. Epigenetics Diagnostic Introduction

11.2.4 Thermo Fisher Scientific, Inc. Revenue in Epigenetics Diagnostic Business (2019-2024)

11.2.5 Thermo Fisher Scientific, Inc. Recent Developments

11.3 Eisai Co. Ltd.

11.3.1 Eisai Co. Ltd. Company Details

11.3.2 Eisai Co. Ltd. Business Overview

11.3.3 Eisai Co. Ltd. Epigenetics Diagnostic Introduction

11.3.4 Eisai Co. Ltd. Revenue in Epigenetics Diagnostic Business (2019-2024)

11.3.5 Eisai Co. Ltd. Recent Developments

11.4 Novartis AG

11.4.1 Novartis AG Company Details

11.4.2 Novartis AG Business Overview

11.4.3 Novartis AG Epigenetics Diagnostic Introduction

11.4.4 Novartis AG Revenue in Epigenetics Diagnostic Business (2019-2024)

11.4.5 Novartis AG Recent Developments

11.5 Illumina, Inc.

11.5.1 Illumina, Inc. Company Details

11.5.2 Illumina, Inc. Business Overview

11.5.3 Illumina, Inc. Epigenetics Diagnostic Introduction

11.5.4 Illumina, Inc. Revenue in Epigenetics Diagnostic Business (2019-2024)

11.5.5 Illumina, Inc. Recent Developments

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck Epigenetics Diagnostic Introduction

11.6.4 Merck Revenue in Epigenetics Diagnostic Business (2019-2024)

11.6.5 Merck Recent Developments

11.7 Qiagen

11.7.1 Qiagen Company Details

11.7.2 Qiagen Business Overview

11.7.3 Qiagen Epigenetics Diagnostic Introduction

11.7.4 Qiagen Revenue in Epigenetics Diagnostic Business (2019-2024)

11.7.5 Qiagen Recent Developments

11.8 Abcam plc

11.8.1 Abcam plc Company Details

11.8.2 Abcam plc Business Overview

11.8.3 Abcam plc Epigenetics Diagnostic Introduction

11.8.4 Abcam plc Revenue in Epigenetics Diagnostic Business (2019-2024)

11.8.5 Abcam plc Recent Developments

11.9 Diagenode Diagnostics

11.9.1 Diagenode Diagnostics Company Details

11.9.2 Diagenode Diagnostics Business Overview

11.9.3 Diagenode Diagnostics Epigenetics Diagnostic Introduction

11.9.4 Diagenode Diagnostics Revenue in Epigenetics Diagnostic Business (2019-2024)

11.9.5 Diagenode Diagnostics Recent Developments

11.10 Active Motif

11.10.1 Active Motif Company Details

11.10.2 Active Motif Business Overview

11.10.3 Active Motif Epigenetics Diagnostic Introduction

11.10.4 Active Motif Revenue in Epigenetics Diagnostic Business (2019-2024)

11.10.5 Active Motif Recent Developments

11.11 Zymo Research Corporation

11.11.1 Zymo Research Corporation Company Details

11.11.2 Zymo Research Corporation Business Overview

11.11.3 Zymo Research Corporation Epigenetics Diagnostic Introduction

11.11.4 Zymo Research Corporation Revenue in Epigenetics Diagnostic Business (2019-2024)

11.11.5 Zymo Research Corporation Recent Developments

11.12 CellCentric

11.12.1 CellCentric Company Details

11.12.2 CellCentric Business Overview

11.12.3 CellCentric Epigenetics Diagnostic Introduction

11.12.4 CellCentric Revenue in Epigenetics Diagnostic Business (2019-2024)

11.12.5 CellCentric Recent Developments

11.13 Valirx

11.13.1 Valirx Company Details

11.13.2 Valirx Business Overview

11.13.3 Valirx Epigenetics Diagnostic Introduction

11.13.4 Valirx Revenue in Epigenetics Diagnostic Business (2019-2024)

11.13.5 Valirx Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Roche Diagnostics

Thermo Fisher Scientific Inc

Eisai Co Ltd

Novartis

Illumina Inc

Merck

Qiagen NV

Abcam

Diagenode Diagnostics

Active Motif

Zymo Research Corporation

CellCentric

ValiRx Plc

List of Tables

Table 1. Global Epigenetics Diagnostic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Reagents

Table 3. Key Players of Kits

Table 4. Key Players of Instruments

Table 5. Key Players of Enzymes

Table 6. Key Players of Services

Table 7. Global Epigenetics Diagnostic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Epigenetics Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Epigenetics Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Epigenetics Diagnostic Market Share by Region (2019-2024)

Table 11. Global Epigenetics Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Epigenetics Diagnostic Market Share by Region (2025-2030)

Table 13. Epigenetics Diagnostic Market Trends

Table 14. Epigenetics Diagnostic Market Drivers

Table 15. Epigenetics Diagnostic Market Challenges

Table 16. Epigenetics Diagnostic Market Restraints

Table 17. Global Epigenetics Diagnostic Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Epigenetics Diagnostic Revenue Share by Players (2019-2024)

Table 19. Global Top Epigenetics Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics Diagnostic as of 2023)

Table 20. Global Epigenetics Diagnostic Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Epigenetics Diagnostic Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Epigenetics Diagnostic, Headquarters and Area Served

Table 23. Global Key Players of Epigenetics Diagnostic, Product and Application

Table 24. Global Key Players of Epigenetics Diagnostic, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Epigenetics Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Epigenetics Diagnostic Revenue Market Share by Type (2019-2024)

Table 28. Global Epigenetics Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Epigenetics Diagnostic Revenue Market Share by Type (2025-2030)

Table 30. Global Epigenetics Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Epigenetics Diagnostic Revenue Share by Application (2019-2024)

Table 32. Global Epigenetics Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Epigenetics Diagnostic Revenue Share by Application (2025-2030)

Table 34. North America Epigenetics Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Epigenetics Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Epigenetics Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Epigenetics Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Epigenetics Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Epigenetics Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Epigenetics Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Epigenetics Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Epigenetics Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Epigenetics Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Epigenetics Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Epigenetics Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Epigenetics Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Epigenetics Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Epigenetics Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Epigenetics Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Epigenetics Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Epigenetics Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Epigenetics Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Epigenetics Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Epigenetics Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Epigenetics Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Epigenetics Diagnostic Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Epigenetics Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Epigenetics Diagnostic Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Epigenetics Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 66. Roche Diagnostics Company Details

Table 67. Roche Diagnostics Business Overview

Table 68. Roche Diagnostics Epigenetics Diagnostic Product

Table 69. Roche Diagnostics Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 70. Roche Diagnostics Recent Developments

Table 71. Thermo Fisher Scientific, Inc. Company Details

Table 72. Thermo Fisher Scientific, Inc. Business Overview

Table 73. Thermo Fisher Scientific, Inc. Epigenetics Diagnostic Product

Table 74. Thermo Fisher Scientific, Inc. Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 75. Thermo Fisher Scientific, Inc. Recent Developments

Table 76. Eisai Co. Ltd. Company Details

Table 77. Eisai Co. Ltd. Business Overview

Table 78. Eisai Co. Ltd. Epigenetics Diagnostic Product

Table 79. Eisai Co. Ltd. Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 80. Eisai Co. Ltd. Recent Developments

Table 81. Novartis AG Company Details

Table 82. Novartis AG Business Overview

Table 83. Novartis AG Epigenetics Diagnostic Product

Table 84. Novartis AG Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 85. Novartis AG Recent Developments

Table 86. Illumina, Inc. Company Details

Table 87. Illumina, Inc. Business Overview

Table 88. Illumina, Inc. Epigenetics Diagnostic Product

Table 89. Illumina, Inc. Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 90. Illumina, Inc. Recent Developments

Table 91. Merck Company Details

Table 92. Merck Business Overview

Table 93. Merck Epigenetics Diagnostic Product

Table 94. Merck Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 95. Merck Recent Developments

Table 96. Qiagen Company Details

Table 97. Qiagen Business Overview

Table 98. Qiagen Epigenetics Diagnostic Product

Table 99. Qiagen Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 100. Qiagen Recent Developments

Table 101. Abcam plc Company Details

Table 102. Abcam plc Business Overview

Table 103. Abcam plc Epigenetics Diagnostic Product

Table 104. Abcam plc Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 105. Abcam plc Recent Developments

Table 106. Diagenode Diagnostics Company Details

Table 107. Diagenode Diagnostics Business Overview

Table 108. Diagenode Diagnostics Epigenetics Diagnostic Product

Table 109. Diagenode Diagnostics Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 110. Diagenode Diagnostics Recent Developments

Table 111. Active Motif Company Details

Table 112. Active Motif Business Overview

Table 113. Active Motif Epigenetics Diagnostic Product

Table 114. Active Motif Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 115. Active Motif Recent Developments

Table 116. Zymo Research Corporation Company Details

Table 117. Zymo Research Corporation Business Overview

Table 118. Zymo Research Corporation Epigenetics Diagnostic Product

Table 119. Zymo Research Corporation Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 120. Zymo Research Corporation Recent Developments

Table 121. CellCentric Company Details

Table 122. CellCentric Business Overview

Table 123. CellCentric Epigenetics Diagnostic Product

Table 124. CellCentric Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 125. CellCentric Recent Developments

Table 126. Valirx Company Details

Table 127. Valirx Business Overview

Table 128. Valirx Epigenetics Diagnostic Product

Table 129. Valirx Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)

Table 130. Valirx Recent Developments

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Epigenetics Diagnostic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Epigenetics Diagnostic Market Share by Type: 2023 VS 2030

Figure 3. Reagents Features

Figure 4. Kits Features

Figure 5. Instruments Features

Figure 6. Enzymes Features

Figure 7. Services Features

Figure 8. Global Epigenetics Diagnostic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Epigenetics Diagnostic Market Share by Application: 2023 VS 2030

Figure 10. Oncolog Case Studies

Figure 11. Non-oncology Case Studies

Figure 12. Epigenetics Diagnostic Report Years Considered

Figure 13. Global Epigenetics Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Epigenetics Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Epigenetics Diagnostic Market Share by Region: 2023 VS 2030

Figure 16. Global Epigenetics Diagnostic Market Share by Players in 2023

Figure 17. Global Top Epigenetics Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics Diagnostic as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Epigenetics Diagnostic Revenue in 2023

Figure 19. North America Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Epigenetics Diagnostic Market Share by Type (2019-2030)

Figure 21. North America Epigenetics Diagnostic Market Share by Application (2019-2030)

Figure 22. North America Epigenetics Diagnostic Market Share by Country (2019-2030)

Figure 23. United States Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Epigenetics Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Epigenetics Diagnostic Market Share by Type (2019-2030)

Figure 27. Europe Epigenetics Diagnostic Market Share by Application (2019-2030)

Figure 28. Europe Epigenetics Diagnostic Market Share by Country (2019-2030)

Figure 29. Germany Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Epigenetics Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Epigenetics Diagnostic Market Share by Type (2019-2030)

Figure 37. China Epigenetics Diagnostic Market Share by Application (2019-2030)

Figure 38. Asia Epigenetics Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Epigenetics Diagnostic Market Share by Type (2019-2030)

Figure 40. Asia Epigenetics Diagnostic Market Share by Application (2019-2030)

Figure 41. Asia Epigenetics Diagnostic Market Share by Region (2019-2030)

Figure 42. Japan Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Epigenetics Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Epigenetics Diagnostic Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Epigenetics Diagnostic Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Epigenetics Diagnostic Market Share by Country (2019-2030)

Figure 52. Brazil Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Roche Diagnostics Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 59. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 60. Eisai Co. Ltd. Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 61. Novartis AG Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 62. Illumina, Inc. Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 63. Merck Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 64. Qiagen Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 65. Abcam plc Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 66. Diagenode Diagnostics Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 67. Active Motif Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 68. Zymo Research Corporation Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 69. CellCentric Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 70. Valirx Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Precision Medicine Diagnostics Market

Global Epigenome Analysis Market Research Report 2025

Epigenetics Drugs Diagnostic Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Epigenetic Therapeutics Market Research Report 2024

Global Epigenetics Instrument Market Research Report 2025

Precision Cancer Diagnostic Tests Market

Global Epigenome Analysis Services Market Research Report 2024

Global Breast Cancer Diagnostic Technologies Market Insights Forecast to 2030

Global Tumor Marker Testing Market Research Report 2024

Epigenetic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Epigenetics Services Market Research Report 2024

Global Hematology Oncology Diagnostics Market Research Report 2024

Global Epigenetic Kits Market Research Report 2024

Global Epigenome Sequencing Market Research Report 2024

Global PCR and NGS Based Molecular Diagnostics Market Insights Forecast to 2030

Global Whole Transcriptomics Sequencing Market Insights Forecast to 2030

Global Molecular Diagnosis and Therapy Market Insights Forecast to 2030

Global Methylation Analysis Market Research Report 2025

Global Animal Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Women s Health Diagnostics Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions